Article info

Download PDFPDF

Correspondence on: ‘Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation—an open-label cohort study’ by Della-Torre et al
Free

Authors

  1. Correspondence to Dr Fangjie Zhang, Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha, China; zhangfj11{at}163.com
View Full Text

Citation

Cheng C, Zhang F
Correspondence on: ‘Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation—an open-label cohort study’ by Della-Torre et al

Publication history

  • Received July 17, 2020
  • Revised July 24, 2020
  • Accepted July 27, 2020
  • First published August 19, 2020.
Online issue publication 
September 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.